Infinium Global Research

Global Hypertension Drugs Market Analysis and Value Forecast Snapshot by End-Use Industry 2019-2025

A recent report published by Infinium Global Research on hypertension drugs market provides an in-depth analysis of segments and sub-segments in the global as well as regional hypertension drugs market


Pune, India -- (SBWIRE) -- 12/02/2019 -- Infinium Global Research has recently published a report on the "Hypertension Drugs Market (Analysis Type - Systemic Hypertension Drugs, and Pulmonary Hypertension Drugs; Therapy Type - Calcium Channel Blockers, Diuretics, Beta Blockers Vasodilators, Angiotensin-Converting Enzyme Inhibitor, Alpha Blockers, Angiotensin Receptor Blockers, and Renin Inhibitors; Distribution Channels - Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy): Global Industry Analysis, Trends, Size, Share and Forecasts to 2025." The global hypertension drugs market is projected to grow at a CAGR of 3.5% over the forecast period of 2019-2025.

For More Details Get FREE Sample Pages of this Premium Global Report@

Hypertension affects one in three Americans. The stressful lifestyle, unhealthy diet, physical inactivity, cigarette smoking, and high intake of alcohol are augmenting the prevalence of hypertension among individuals. The shifting trend towards managing hypertension is increasing the demand for hypertension drugs over the globe.

Growing Population of Aging Adults Propel the Market For Hypertension Drugs

The increasing rates of hypertension act as a major driver for the growth of the hypertension drugs market. In addition, the aging population is also expected to drive the demand for hypertension drugs as they have a high risk of hypertension. Furthermore, a sedentary lifestyle and changing dietary habits have led to a significant increase in hypertension. However, the high cost the of the hypertension drugs restraints the growth of the market. Moreover, increasing research and development is anticipated to create fruitful opportunities for the growth of the hypertension drugs market.

Diuretic Segment Anticipated to Hold a Dominant Share in the Global Hypertension Drugs Market

The report on the global Hypertension Drugs market is bifurcated into analysis type, therapy type, and distribution channels. Based on the analysis type, the markets are further bifurcated into systemic hypertension drugs and pulmonary hypertension drugs. Based on therapy type, the markets are further divided into the calcium channel blockers, diuretics, beta-blockers vasodilators, angiotensin-converting enzyme inhibitor, alpha-blockers, angiotensin receptor blockers, and renin inhibitors. Among them, the diuretics segment held a major market share in the Hypertension Drugs market in 2017. Diuretics are used largely as they help the body eliminate excess salt and water by increasing urine output. Based on distribution channels, the markets are further classified into hospital pharmacy, retail pharmacy, and online pharmacy. Among them, the retail pharmacy held the largest share in 2017.

Enquire here Get Customization & Check Discount for Report @

Due to the High Prevalence of Hypertension North America Dominates the Region of Hypertension Drugs Market

North America holds the largest share in the global hypertension drugs market. The U.S. is the key country that contributes to the largest revenue in the North America Hypertension Drugs market owing to the high prevalence of hypertension in the U.S. According to statistics from the American Heart Association, An estimated 103 million U.S. adults have high blood pressure. In addition, favorable reimbursement policies contribute to the growth of the North America hypertension drugs market. Furthermore, Asia Pacific is expected to grow at the highest CAGR over the forecast period owing to the changing lifestyle, increasing occurrence of hypertension and rising middle-class income.

Hypertension Drugs Market: Competitive Landscape

The hypertension drugs market is a highly competitive market. The key players in the Hypertension Drugs market are Pfizer, Inc., AstraZeneca plc, Novartis AG, Daiichi Sankyo Company, Ltd., United Therapeutics Corporation, Sanofi S.A., Johnson & Johnson Services, Inc., Boehringer Engelheim GmbH, Takeda Pharmaceutical Company, and Bayer AG among others.

Browse Complete Global Report and Detailed TOC:

Reasons to Buy this Report:

=> Comprehensive analysis of global as well as regional markets of the Hypertension Drugs.

=> Complete coverage of all the product type and application segments to analyze the trends, developments, and forecast of market size up to 2025.

=> Comprehensive analysis of the companies operating in this market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and the latest developments of the company.  

=> Infinium Global Research- Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.